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innumerable sites throughout the genome 
in a pattern that correlates closely with the 
distribution of H3K4me3 modified chro-
matin. Thus, the overwhelming majority of 
RAG2 in nuclei is bound at sites other than 
actively rearranging antigen receptor gene 
segments. This extremely broad distribu-
tion of binding sites is analogous to that 
seen in genome-wide analyses of tran-
scription factor binding (Orian et al., 2003). 
The authors suggest that the absence of 
associated RAG1 implies that these are 
innocuous binding events rather than ante-
cedents of inappropriate rearrangement.
Thus, interactions of RAG1 and RAG2 
with RSS DNA and H3K4me3 sites in 
chromatin play critical roles in the regula-
tion of V(D)J recombination. This conclu-
sion, however, must be reconciled with 
the findings of two independent analyses 
of mutant mice engineered to lack the 
C-terminal domain of RAG2 that is neces-
sary for binding to H3K4me3 (Akamatsu et 
al., 2003; Liang et al., 2002). These core-
RAG2 mutant mice show a partial block in 
B and T cell development at the V-to-DJ 
stage of IgHC and TCRβ gene rearrange-
ment, but they show normal rates of Igκ 
and TCRα rearrangement and intact allelic 
exclusion. Perhaps the roles of RSSs 
and H3K4me3-modified histones in RAG 
recruitment differ at different loci depend-
ing on RSS sequence characteristics or 
other aspects of chromatin structure. It 
is also possible that H3K4me3 does not 
play a key role in RAG recruitment, but 
rather activates the cleavage activity of the 
recombinase. In this model, intact RAG2 
would be in an autoinhibited state that 
could be activated by binding of H3K4me3 
to its PHD domain or by the deletion of its 
C-terminal region. Additional important 
questions remain, such as how V gene 
segment RSSs are captured by J proximal 
RAG-RSS complexes. Perhaps ChIP-seq 
results are misleading in the V region of 
rearranging loci as recombinases might be 
bound to small subsets of the >100 V seg-
ments in each locus that differ from cell to 
cell and result in the apparent absence of 
RAG binding to the “average” V segment. 
It will also be critical to determine the frac-
tion of unbound RAG1 and RAG2 in nuclei 
that exist in complexes with one another 
to understand in more detail the recruit-
ment process. Finally, the idea of recom-
bination centers may prove important for 
the mechanism of allelic exclusion and the 
minimization of inappropriate V(D)J recom-
bination. Confirmation of this model by 
direct visualization of such centers would 
represent an important next step.
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The mechanism by which the apoptosome activates caspases during apoptosis has been contro-
versial. Qi et al. (2010) now present a crystal structure of a funnel-shaped octameric apoptosome 
complex from the nematode Caenorhabditis elegans that challenges currently held assumptions 
about the human apoptosome structure.During apoptosis, caspases cleave key 
intracellular target proteins to promote 
the death of the cell and disposal of the 
cell corpse. The first caspases activated 
during this process are the initiator cas-402 Cell 141, April 30, 2010 ©2010 Elsevier Ipases, which in turn cleave and activate 
the executioner caspases. The activation 
of initiator caspases is highly regulated, 
and it is thought to involve their dimeriza-
tion, but the detailed mechanisms remain nc.unclear. In mammals, activation of ini-
tiator caspase-9 requires the assembly 
of a heptameric wheel-like complex of 
Apaf-1 molecules known as the apopto-
some. Once assembled the apoptosome 
recruits and activates initiator caspase-9 
(Bao and Shi, 2007). However, here is 
where the controversies begin, in part 
because a high-resolution structure of the 
apoptosome has not been available, until 
now. In this issue, Qi et al. (2010) present 
an impressive feat—the first crystal struc-
ture of a complete apoptosome at 3.55 Å 
resolution.
The structure is an octamer of CED-4, 
the Caenorhabditis elegans ortholog of 
Apaf-1. CED-4 and Apaf-1 belong to a 
new class of signal transduction AAA+ 
proteins (Danot et al., 2009). They have 
an N-terminal caspase recruitment 
domain (CARD) and an NB-ARC region, 
which is composed of an α/β domain 
and a helical domain 1 (HD1), followed 
by a winged-helix domain (WHD) and a 
second helical domain (HD2) (Figure 1A). 
In healthy cells, CED-4 is sequestered 
by CED-9 (homologous to mammalian 
Bcl-2) into a (CED-4)2:CED-9 complex, in 
which the CED-4 molecules exist as an 
asymmetric dimer. In the presence of a 
death signal, an upstream protein EGL-1 
(analogous to mammalian BH3-only pro-
teins) interacts with CED-9 and releases 
the CED-4 dimer to become activated 
(Yan et al., 2005). The structural compari-
sons performed by Qi et al. show that the 
conformation of the asymmetric CED-4 
dimer in the apoptosome is nearly identi-
cal to that found in the (CED-4)2:CED-9 
complex, indicating that the CED-4 
dimer sequestered by CED-9 does not 
undergo major conformational changes 
before assembling into an apoptosome. 
This hypothesis is supported by the fact 
that CED-4 binds ATP when it is seques-
tered by CED-9. This is unlike autoin-
hibited Apaf1, which is ADP bound and 
needs ADP/ATP exchange to undergo a 
conformational change before assem-
bling into an apoptosome, and does not 
involve Bcl-2 proteins.
This structure contrasts with the 
tetramer model proposed earlier by this 
group (Yan et al., 2005), but the reason 
for this difference is now clear. A tetramer 
of asymmetric CARD dimers results in 
the protrusion of alternate N-terminal 
CARDs at the top of the apoptosome, 
explaining the unoccupied electron den-
sities of the previous model (Figure 1B). 
Overall, the CED-4 apoptosome has an 
inverted funnel-like structure, rather than 
the flat structure proposed for Apaf-1.For now, the only available crystal struc-
ture of Apaf-1 is for the inhibited (ADP-
bound) monomer, which lacks the WD-40 
domain (Riedl et al., 2005). A heptameric 
Apaf-1 apoptosome structure was previ-
ously obtained by cryoelectron micros-
copy at 12.8 Å resolution. Docking the 
crystal structure of individual domains 
from the inhibited monomeric Apaf-1 into 
this EM structure of the Apaf-1 apopto-
some reveals a flat wheel-like structure, 
with seven CARDs arranged as a ring in 
the center of the wheel (Yu et al., 2005). Qi 
et al. model the Apaf-1 apoptosome in a 
different way, providing a challenge to the 
previous structure. Although the overall 
structure of CED-4 differs from that of the 
inhibited monomeric Apaf-1, the structure 
of individual domains such as CARD, α/β, 
HD1, and WHD are very similar between 
CED-4 and Apaf-1. Therefore, the authors 
model the active Apaf-1 monomer by fit-
ting the individual domains into their corre-
sponding positions in the CED-4 apopto-
some. Using this putative activated form of 
monomeric Apaf-1 to generate the Apaf-1 
apoptosome structure, they derive a cone-
shaped structure held together by an inner 
ring composed of the α/β domain (rather Cell 1than the CARD) and a loose ring of CARDs 
positioned on top (Figure 1C). This posi-
tion of the CARD of CED-4 is similar to a 
previous model of the Apaf-1 apoptosome 
derived from the structure of the classic 
AAA+ ATPase (STAND) complex (Danot et 
al., 2009), in which the center of the wheel 
is composed of the ATPase (α/β domain—
HD1) domain, with the CARDs forming a 
looser ring on top (Diemand and Lupas, 
2006). To provide experimental support for 
this revised model of the Apaf-1 apopto-
some, Qi et al. generate point mutants pre-
dicted to disrupt the interactions between 
the α/β domain interfaces. They success-
fully identify four mutants that fail to form 
the apoptosome, supporting the notion 
that the Apaf-1 apoptosome is similar to 
the CED-4 apoptosome.
How does the funnel-shaped apopto-
some activate caspases? The authors 
incubate processed CED-3 (the ortholog 
of caspase-9) with CED-4 to generate the 
CED-4:CED-3 apoptosome complex. Sur-
prisingly, the molar ratio of CED-4 to CED-3 
in this complex is 4:1, meaning that there is 
a single active CED-3 protease dimer per 
apoptosome. Structure analysis by cryo-
electron microscopy indicates that the figure 1. structure of ceD-4 and Apaf-1 Apoptosomes
(A) Conserved domains between Caenorhabditis elegans CED-4 (571 amino acids) and human Apaf-1 
(1237 amino acids).
(B) The C. elegans CED-4 octamer apoptosome as viewed from the top (upper) and side (lower). 
(C) Human Apaf-1 heptamer apoptosome as viewed from the top (upper) and side (lower).41, April 30, 2010 ©2010 Elsevier Inc. 403
CED-3 caspase dimer resides inside the 
cone-shaped hutch of the CED-4 apopto-
some, visible from the open bottom-side 
of the funnel. Biochemical experiments 
indicate that the CED-4 apoptosome pro-
motes dimerization of processed CED-3 
and enhances its protease activity. This 
finding is consistent with the previously 
hypothesized model in which caspase 
dimerization is driven by proximity.
It remains unclear how the CED-3 
zymogen is recruited and activated by 
the apoptosome. With the CED-4 CARD 
perched on top of the apoptosome, it 
is not obvious how the CARD of CED-4 
and the CARD of CED-3 would make 
contact when the active CED-3 dimer 
is inside the hutch. One caveat of this 
study is that the structure represents 
fully processed CED-3 lacking its CARD, 
as the CARD renders CED-3 insoluble. 
Therefore, the role of the CED-3 CARD in 
caspase recruitment and activation is an 
intriguing topic for future study.
The structural and biochemical analy-
ses of the (CED-4)8:(CED-3)2 complex 
also has implications for caspase-9 acti-
vation by the Apaf-1 apoptosome. It is 
generally assumed that the CARD in the 
Apaf-1 apoptosome binds the CARD 
domain of caspase-9 to cause proximity-
driven dimerization of caspase-9 (Pop et 
al., 2006). For example, forced dimeriza-
tion of caspase-9 by replacing its CARD 404 Cell 141, April 30, 2010 ©2010 Elsevier I
Endocytosis starts with the generation 
of endocytic vesicles at the plasma 
membrane, which then fuse with the 
early endosome. The early endosome is 
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In the endocytic pathway, early 
their associated Rab GTPases. 
protein as a switch that shuts off
of the next (Rab7).with a leucine zipper dimerization motif 
is sufficient for caspase-9 autoactivation. 
However, the oligomeric Apaf-1 apopto-
some even more effectively enhances 
caspase-9 activity for its downstream tar-
get, caspase-3 (Yin et al., 2006). The exact 
action of the apoptosome on the caspase 
to achieve this level of activity is unclear, in 
part because the stoichiometry of the Apaf-
1:caspase-9 complex in the holoenzyme 
is still debated. One possibility is that the 
Apaf-1 apoptosome recruits seven mole-
cules of caspase-9 through CARD-CARD 
interactions at a 1:1 ratio with Apaf-1. An 
alternate view comes from an elegant bio-
chemical study reporting that only one to 
two molecules of caspase-9 are recruited 
to the Apaf-1 apoptosome (Malladi et al., 
2009). This is consistent with the (CED-
4)8:(CED-3)2 model now reported by Shi’s 
group. However, unlike CED-3, which has 
its CARD removed when the zymogen is 
matured by proteolysis, the activated cas-
pases-9 retains its CARD. This difference 
raises the question of how caspase-9 is 
activated by the Apaf-1 apoptosome. If the 
CARD of Apaf-1 recruits the CARD of cas-
pase-9, as generally assumed, then the 
activated caspase-9 will be sitting on the 
top of the apoptosome (or between higher-
order multi-apoptosome complexes). This 
study suggests that the hutch under the 
CED-4 cone-shaped apoptosome may 
constrain the CED-3 caspase in a unique nc.
a hub for multiple pathways, including 
the recycling of cell surface receptors, 
the fusion of vesicles derived from the 
Golgi apparatus, and the sorting of pro-
mal Maturation
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endosomes are converted into la
In this issue, Poteryaev et al. (20
 the recruitment of one Rab (Rabactivation step. Assuming that the Apaf-1 
apoptosome is similar in structure to the 
CED-4 apoptosome, an Apaf-1 hutch 
theoretically could drive dimerization and 
activation of caspase-9. Although this 
remarkable new structure challenges the 
dogma, there are now many new impor-
tant questions to pursue.
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